Portfolio
2
companies
Carcinotech
Carcinotech manufactures 3D printed tumours from cancer cells for oncology testing and research.
Dyneval
Dyneval produces advanced semen analysis technology for veterinary and fertility applications.
The Edinburgh biotech uses the capital to scale its 3D bioprinted tumour models across the UK, Europe, and the US.
"Our vision is to be at the forefront of cancer drug testing and provide personalised medicine testing to every individual suffering from cancer to improve their treatment and chance of survival. Working with global partners, leading pharma companies, surgeons, pathologists, and clinicians, Carcinotech aims to accelerate oncology drug development significantly."
The Edinburgh based agritech firm has raised over half a million pounds to accelerate manufacturing of its portable semen testing device.
"We are very proud to secure this additional round of funding which will help to rapidly increase our production meaning we can help even more farmers across Scotland, the UK and beyond."
TRICAPITAL led the investment round with backing from a syndicate of Scottish investors.
"Our next phase of growth will involve building international partnerships, growing the team, and appointing a scientific advisory committee to support the work of the main board."
